As of 2025-04-22, the EV/EBITDA ratio of Revolution Medicines Inc (RVMD) is -9.77. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RVMD's latest enterprise value is 6,253.81 mil USD. RVMD's TTM EBITDA according to its financial statements is -639.94 mil USD. Dividing these 2 quantities gives us the above RVMD EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-04-21 | -9.84 |
| 2025-04-17 | -9.83 |
| 2025-04-16 | -9.67 |
| 2025-04-15 | -9.70 |
| 2025-04-14 | -9.75 |
| 2025-04-11 | -9.53 |
| 2025-04-10 | -8.93 |
| 2025-04-09 | -9.35 |
| 2025-04-08 | -8.19 |
| 2025-04-07 | -8.27 |
| 2025-04-04 | -8.25 |
| 2025-04-03 | -8.70 |
| 2025-04-02 | -9.20 |
| 2025-04-01 | -8.92 |
| 2025-03-31 | -9.42 |
| 2025-03-28 | -10.00 |
| 2025-03-27 | -10.22 |
| 2025-03-26 | -10.11 |
| 2025-03-25 | -10.32 |
| 2025-03-24 | -10.58 |
| 2025-03-21 | -10.22 |
| 2025-03-20 | -10.33 |
| 2025-03-19 | -10.41 |
| 2025-03-18 | -10.24 |
| 2025-03-17 | -10.52 |
| 2025-03-14 | -10.52 |
| 2025-03-13 | -10.49 |
| 2025-03-12 | -10.54 |
| 2025-03-11 | -10.45 |
| 2025-03-10 | -9.85 |
| 2025-03-07 | -10.54 |
| 2025-03-06 | -10.55 |
| 2025-03-05 | -10.66 |
| 2025-03-04 | -10.18 |
| 2025-03-03 | -10.29 |
| 2025-02-28 | -10.99 |
| 2025-02-27 | -10.50 |
| 2025-02-26 | -10.92 |
| 2025-02-25 | -11.16 |
| 2025-02-24 | -11.13 |
| 2025-02-21 | -11.16 |
| 2025-02-20 | -11.43 |
| 2025-02-19 | -11.45 |
| 2025-02-18 | -11.20 |
| 2025-02-14 | -10.97 |
| 2025-02-13 | -11.16 |
| 2025-02-12 | -11.35 |
| 2025-02-11 | -11.19 |
| 2025-02-10 | -11.37 |
| 2025-02-07 | -11.41 |